Summary
In a series of 20 patients undergoing elective colorectal surgery, 10 received an infusion of metronidazole 500 mg and 10 an infusion of 1500 mg commencing at the induction of anaesthesia. The concentrations of metronidazole in the plasma, rectus muscle and colon of the two groups during the course of the operation were compared. In those patients who received 1500 mg, the plasma and tissue concentrations were all well above the minimum inhibitory concentration (MIC) of metronidazole against Bacteroides fragilis. In those patients who received 500 mg, serum and tissue concentrations were at or only just above the MIC. It may be that 1500 mg would be a more effective dose of metronidazole for prophylactic use in colorectal surgery. sampled at 20·minute intervals for up to 100 minutes from the start of the infusion. A sample of rectus muscle was taken at the time of wound closure. A fullthickness sample of colon was taken from the resected specimen immediately after its removal. Blood samples were collected in heparinized bottles. The plasma was separated and stored at -20°C. Tissue samples were stored dry at -20°C. Tissue was prepared for assay by homogenization of 0.5 g of tissue with 0.5 ml of water. After centrifugation the supernatant was treated as for plasma. The metronidazole assay was performed using high pressure liquid chromatography'', The antibiotic concentrations in the two groups were compared using the Mann-Whitney U test. 
Results

Plasma
The plasma concentrations of metronidazole at the five time points of the study are shown in Figure 1 . The concentrations of Group 2 were significantly higher than those of Group 1 at 40 minutes (z=3.062, P=0.002), 60 minutes (z=3. 704, P=O.OOl), 80 minutes (z=3.780, P=O.OOl) and 100 minutes (z=3.780, P=O.OOl) after the start of the infusion. All the measured concentrations were above the MIC, which was taken to be 6. Prior to the development of antibiotics effective against anaerobic organisms, wound infection rates of more than 50% were reported for elective colorectal surgeryl.2. The use of metronidazole 500 mg infused intravenously at the start of the operation, either with or without an antibiotic active against aerobic bacteria, has reduced the wound infection rate to between 7% and 20%3-6. In most reported series, Bacteroides fragilis has been cultured from at least some of the infected wounds in spite of the use of metronidazole. Our own experience with the use of a prophylactic dose of metronidazole 500 mg was that B. fragilis was isolated from 8% of infected wounds", which suggested that in some patients the prophylaxis was inadequate. Solhaug et al. 8 studied the use of a single dose of metronidazole 1500 mg and reported that serum metronidazole concentrations remained above the mean inhibitory concentration (MIC) of metronidazole against B. fragilis for 36 hours. The present study was undertaken to compare the plasma and tissue concentrations of metronidazole during the operative period following infusions of 1500 mg and 500 mg, commencing at the induction of anaesthesia.
Patients and methods
Twenty patients undergoing elective colorectal surgery were included in the study. All patients received mechanical bowel preparation but no preoperative antibiotics. Each patient was randomly allocated to one of two groups: Group 1 (10 patients) received metronidazole 500 mg by intravenous infusion over 20 minutes; Group 2 (10 patients) received metronidazole 1500 mg over 60 minutes. In all patients infusion was started in the anaesthestic room immediately prior to surgery. Venous blood was minute period, the concentrations in Group 1 were of the order of 2 to 3 times the MIC, whereas those in Group 2 were of the order of 5 to 6 times the MIC.
Rectus muscle
The rectus muscle concentrations of metronidazole at the time of wound closure are shown in Figure 2 . The concentrations of Group 2 were significantly higher than those of Group 1 (z=2.646, P=0.008). Some of the concentrations in Group 1 were only just above the MIC.
Colon
The colon concentrations of metronidazole in the resected specimen are shown in Figure 2 . The concentrations of Group 2 were significantly higher than those of Group 1 (z=2.948, P=O.028). In 4 patients in Group 1 the concentration was below the MIC.
Clinical effect
One patient in each group developed a wound infection. Clearly the numbers of patients are too small for any conclusions about the relative efficacy of the two concentrations to be drawn. None of the patients in Group 2 developed any neurological or other side effects.
Discussion
This study has demonstrated that the infusion of metronidazole 1500 mg during the operative period does result in significantly higher plasma and tissue concentrations than the infusion of 500 mg. Whether the higher concentration achieved with the higher dose is clinically important will depend on how the concentrations compare with the MIC of metronidazole against B. fragilis. This is usually taken to be 6.2~g/ml. Tally et al. 1O reported that 51 out of 54 strains of anaerobes were inhibited by metronidazole concentrations of6.2~g/ml or less. One of the strains of B. fragilis tested had an MIC of 25~g/ml. Chow et al. 11 reported that 92% of strains of B. fragilis were inhibited by a metronidazole concentration of 6.25~g/ml. Thus peroperative plasma and tissue concentrations of 6.2~g/ml would be expected to inhibit most but not all strains of B. fragilis.
Houghton et 01. 12 , investigating the pharmacokinetics of metronidazolein healthy female volunteers, reported that a single intravenous dose of500 mg gave a peak plasma concentration of 13.9 flg/ml, and an estimated half-life of 7 hours. Gerloff and Arnold'" found marked individual variation in the plasma concentrations following metronidazole infusion, which they attributed to individual differences in the rates of metabolism and of renal clearance. The patients in Group 1 in whom the plasma, rectus and colonconcentrations were only just above the MIC may have been rapid metabolizers of metronidazole. These patients would require a higher infusion dose if plasma and tissue concentrations comparable to the slower metabolizers are to be achieved. It may be these patients who are prone to develop wound infections when metronidazole 500 mg is used.
The use of metronidazole 1500 mg infused at the beginning of the operation would ensure that all patients achieve adequate concentrations against all strains of B. fragilis.
